id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-304271-vyayyk50	Qin, Yuan-Yuan	Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial	2020-03-05		.txt	text/plain	3984	228	42	title: Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial [9] During the SARS epidemic of 2003, therapeutic systemic glucocorticoids were widely administered in patients who were infected with the severe acute respiratory syndrome coronavirus (SARS-COV), and who subsequently developed severe respiratory disease. [12] In addition, a further retrospective observational study found that glucocorticoid therapy in patients with MERS was associated with delayed Middle East respiratory syndrome coronavirus (MERS-CoV) RNA clearance. [13, 20, 21] Glucocorticoid therapy was used in the treatment of severe SARS because early anecdotal experience supported it, and radiologic findings and histologic features of critically ill patients with SARS were similar to those of patients with acute respiratory distress syndrome (ARDS). Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial	./cache/cord-304271-vyayyk50.txt	./txt/cord-304271-vyayyk50.txt